Abagovomab for ovarian cancer

Author： Pfisterer Jacobus   Harter Philipp   Simonelli Cecilia   Peters Martin   Berek Jonathan   Sabbatini Paul   du Bois Andreas  

Publisher： Informa Healthcare

ISSN： 1471-2598

Source： Expert Opinion on Biological Therapy, Vol.11, Iss.3, 2011-03, pp. : 395-403

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pertuzumab for the treatment of ovarian cancer

By Langdon Simon P   Faratian Dana   Nagumo Yoko   Mullen Peter   Harrison David J  

Expert Opinion on Biological Therapy, Vol. 10, Iss. 7, 2010-07 ,pp. : 1113-1120

Informa Healthcare

Access to resources Recommend Favorite

Immunotherapy of ovarian cancer

By Kirby Tyler O   Alvarez Ronald   Huh Warner  

Expert Opinion on Biological Therapy, Vol. 2, Iss. 4, 2002-04 ,pp. : 409-417

Informa Healthcare

Access to resources Recommend Favorite

Cellular immunotherapy for ovarian cancer

By Cannon Martin J   O'Brien Timothy J  

Expert Opinion on Biological Therapy, Vol. 9, Iss. 6, 2009-06 ,pp. : 677-688

Informa Healthcare

Access to resources Recommend Favorite

Monoclonal antibodies therapies for ovarian cancer

By Leone Roberti Maggiore Umberto   Bellati Filippo   Ruscito Ilary   Gasparri Maria Luisa   Alessandri Franco   Venturini Pier Luigi   Ferrero Simone  

Expert Opinion on Biological Therapy, Vol. 13, Iss. 5, 2013-08 ,pp. : 739-764

Informa Healthcare

Access to resources Recommend Favorite

Ovarian cancer vaccine trials and tribulations

By Buckanovich Ronald J  

Expert Opinion on Biological Therapy, Vol. 7, Iss. 1, 2007-01 ,pp. : 103-112

Informa Healthcare

Access to resources Recommend Favorite